Asthma and high-intensity interval training have no effect on clustered cardiometabolic risk or arterial stiffness in adolescents by Melitta, McNarry et al.
Vol.:(0123456789) 
European Journal of Applied Physiology 
https://doi.org/10.1007/s00421-020-04590-4
ORIGINAL ARTICLE
Asthma and high‑intensity interval training have no effect 
on clustered cardiometabolic risk or arterial stiffness in adolescents
M. A. McNarry1  · L. Lester2 · E. A. Ellins3 · J. P. Halcox3 · G. Davies3 · C. O. N. Winn1 · K. A. Mackintosh1
Received: 24 June 2020 / Accepted: 17 December 2020 
© The Author(s) 2021
Abstract
Purpose Cardiometabolic risk, including arterial stiffness, is increasing in youth. Those with asthma are suggested to be 
particularly at risk of cardiovascular disease. Efficient and effective strategies are required to prevent the atherosclerotic 
process in youth. The purpose of this study was to investigate the effect of 6 months high-intensity interval training (HIIT) 
on cardiometabolic risk in youth with and without asthma.
Methods 65 adolescents (31 mild asthma; 34 non-asthma) were recruited, 32 (16 asthma) of whom were randomly allo-
cated to receive HIIT three times per week for 6 months. At baseline, mid-intervention, post-intervention and at a 3-month 
follow-up, anthropometric, metabolic and vascular determinants of cardiometabolic risk were assessed. Following principal 
component analysis (PCA), linear mixed models were used to assess the influence of asthma, HIIT and their interaction.
Results Seven factors were identified which explained 88% of the common variance shared among the parameters. Those with 
asthma demonstrated lower arterial stiffness factor scores mid-intervention (P = 0.047) and lower cholesterol factor scores 
post-intervention (P = 0.022) but there was no effect of the intervention, or interaction effects, on any PCA-identified factor, 
at any time-point. HIIT was associated with a lower low-density lipoprotein and diastolic blood pressure at mid-intervention.
Discussion Neither arterial stiffness nor clustered cardiometabolic risk are influenced by HIIT in adolescents with or without 
asthma, despite important changes in blood lipid and pressure profiles. Blood pressure, augmentation and pulse wave velocity 
should be considered physiologically distinct constructs and as potential markers of cardiovascular health.
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Abbreviations
Aix  Augmentation index
FENO  Fraction of exhaled nitric oxide
FEV1  Forced expiratory volume in one second
FVC  Forced vital capacity
HIIT  High-intensity interval training
HDL  High-density lipoprotein
HR  Heart rate
LDL  Low-density lipoprotein
MVPA  Moderate-to-vigorous physical activity
PCA  Principal component analysis
PWA  Pulse wave analysis
PWV  Pulse wave velocity
Τ  Total cholesterol
TG  Triglycerides
UK  United Kingdom
Introduction
Asthma, a chronic inflammatory disorder of the airways 
associated with airway obstruction and hyper-responsive-
ness, affects 1 in 11 children in the UK (Asthma UK 2018). 
However, the inflammation that occurs in those with asthma 
is not restricted to the lungs, with elevated pro-inflamma-
tory cytokines leading to systemic inflammation (Wood 
et al. 2012; Girdhar et al. 2011), and potentially the higher 
rate of cardiovascular disease epidemiologically observed 
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in adults with asthma (Onufrak et al. 2007; Schanen et al. 
2005; Iribarren et al. 2012). The underlying atherosclerotic 
process is often initiated during childhood (McGill et al. 
2000; Hong 2010) and is exacerbated and accelerated by 
the presence of cardiometabolic risk factors (Katzmarzyk 
et al. 2004; McGill et al. 2002; Zimmet et al. 2007). Given 
these risk factors are increasingly evident in youth (Owens 
2013), there is a need for primary prevention and interven-
tion strategies that target such modifiable risk factors during 
childhood (Hong 2010).
Cardiorespiratory fitness and exercise are imperative 
for the management of asthma; exercise is associated with 
improved lung function and mental health (Avallone and 
McLeish 2013), as well as helping to prevent, or at least 
diminish, the symptoms of asthma (Andrade et al. 2014; 
Westergren et al. 2016). Furthermore, exercise is suggested 
to be cardioprotective from the development of atherosclero-
sis and subsequent cardiovascular disease (Thompson et al. 
2003). However, interventions seeking to improve cardio-
metabolic health have had varied success.
High-intensity interval training (HIIT) provides a potent 
stimulus to cardiorespiratory fitness and cardiometabolic 
health in youth (Logan et al. 2014; Costigan et al. 2015; 
Eddolls et al. 2017). Potentially beneficial effects of HIIT 
have also been reported for body composition (Westergren 
et al. 2016; Bailey et al. 1995) and some, although not all 
(Aparecido da Silva et al. 2016), have suggested that HIIT 
is less likely to induce bronchoconstriction (O’Neill et al. 
2017; Good et al. 2019). However, the generalizability of 
these findings to a real-world setting is limited by a reliance 
on laboratory-based protocols, relatively short interventions 
and a lack of follow-up (Costigan et al. 2015; Eddolls et al. 
2017; Logan et al. 2014). Weston et al. (2016) developed a 
multi-activity, low-volume, high-intensity games interven-
tion that was delivered in a school-setting, reporting gener-
ally smaller, but nonetheless clinically meaningful, changes 
in triglycerides (TG), waist circumference, moderate-to-vig-
orous physical activity (MVPA) and estimated cardiores-
piratory fitness. However, a methodological limitation of 
this, and, indeed, many earlier studies, is their focus on the 
components of cardiometabolic risk as individual factors, 
despite considerable evidence of the clustering of cardio-
metabolic risk factors (Reaven 1988). Indeed, one factor is 
unlikely to define cardiometabolic health in youth (Stoner 
et al. 2017) and thus influencing individual factors does not 
necessarily translate to beneficial changes in the overall risk 
score. Nonetheless, the specific composition of the clustered 
cardiometabolic risk score in youth continues to be a con-
tentious issue, with recent evidence suggesting that central 
blood pressure and measures of arterial stiffness should be 
included (Stoner et al. 2017).
Arterial stiffness is suggested to represent a powerful 
prognostic tool (Adji et al. 2011), providing an insight to 
the hemodynamic impact of adverse structural changes in 
the arterial system. Asthma is increasingly reported to be 
associated with a higher arterial stiffness in both children 
(Steinmann et al. 2015; Augusto et al. 2017), although it is 
pertinent to note that not all studies have reported such an 
association (Gulen et al. 2015; Özkan et al. 2016). These 
equivocal findings may reflect the wide age, and thus 
maturity, and disease severity ranges within these studies; 
endothelial dysfunction increases during puberty (Augusto 
et al. 2017) and is inversely related to lung function or other 
ratings of disease severity (Steinmann et al. 2015; Sun et al. 
2014; Tuleta et al. 2017). Traditional aerobic exercise is 
associated with significant improvements in arterial stiff-
ness in children (Farpour-Lambert et al. 2009; Meyer et al. 
2006; Watts et al. 2004), but the potential utility of HIIT 
largely remains to be elucidated. Specifically, in the only 
study to date, Chuensiri et al. (2018) reported improvements 
in arterial stiffness and flow-mediated dilation in obese pre-
pubertal boys following a 3-month cycle ergometer-based 
HIIT intervention. However, given the age-related changes 
in pulse wave velocity (PWV; Reusz et al. 2010; Fischer 
et al. 2012; Thurn et al. 2015), the potential presence of 
sex differences (Fischer et al. 2012; Thurn et al. 2015; Cur-
cio et al. 2016), and the lack of consideration of those with 
asthma, further research is required to ascertain whether 
HIIT is effective at improving arterial stiffness in both 
healthy adolescents and those with asthma.
Therefore, the purpose of the present study was to deter-
mine the influence of asthma on the clustering of cardiomet-
abolic risk factors in youth and to investigate the influence of 
a 6-month, school-based HIIT intervention on this clustered 
cardiometabolic risk in adolescents with asthma and their 
healthy age- and sex-matched counterparts. It was hypoth-
esized that those with asthma would be characterized by a 
greater cardiometabolic risk and that the HIIT intervention 
would lead to significant improvements in clustered cardio-
metabolic risk, irrespective of asthma status.
Methods
Participants
A sub-sample of 69 adolescents (13.6 ± 0.9 years; 39 boys; 
36 with asthma) were selected to take part in additional lab-
based testing using stratified randomization in Microsoft 
Excel from 616 participants involved in a larger randomized 
control trial for which participants were recruited from local 
secondary schools (The X4A trial: eXercise for Asthma with 
Commando Joe’s). Sixty-five adolescents provided the meas-
ures at all 4 time-points and were included in this analysis 
(13.5 ± 0.9 years; 37 boys; 33 asthma; Table 1), 32 (19 boys; 
16 asthma) of whom were randomly allocated to receive a 
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6-month intervention. Asthma severity was assessed using 
the Global Initiative for Asthma guidelines (Global Initiative 
for Asthma 2017) and classified according to the medica-
tion step required to achieve asthma control. Participants 
were excluded if they did not have stable asthma, defined as 
having experienced an exacerbation within the last 4 weeks. 
Ethical approval was granted by the institutional research 
ethics committee (ref: 140515 and PG/2014/29). Parent/
guardian consent and child assent were obtained prior to 
participation. Participants in the control group (33 adoles-
cents; 20 boys; 17 asthma) were asked to continue with their 
routine activities.
Intervention
The intervention design was based on formative work 
(Winn et al. 2017) and has been reported previously (Winn 
et al. 2019). Briefly, the intervention consisted of 6 months 
HIIT, with three 30-min sessions per week consisting of 
circuits and games-based activities designed to elicit a 
heart rate of > 90% Heart Rate maximum  (HRmax), with a 
1:1 exercise-to-rest ratio. Throughout the intervention, the 
duration of the exercise bouts was progressively increased 
from 10 to 30 s. Throughout each session, heart rate (HR) 
was continuously monitored for each participant (Activio 
AB, Stockholm, SWE). Maximal HR was predicted using 
the Tanaka et al. (2001) formula, validated for use in adoles-
cents (Mahon et al. 2010). The intervention was delivered by 
a trained professional from Commando Joe’s® (Manchester, 
UK).
Participants were assessed at four time-points baseline, 
mid-intervention (3 months), post-intervention (6 months) 
and at a 3-month post-intervention follow-up. Each partici-
pant was asked to attend the laboratory at the same time 
during the school day (± 2 h), in a hydrated state and at least 
2 h postprandial.
Anthropometrics
Stature and sitting stature were measured to the nearest 
0.1 cm (Seca213, Hamburg, Germany) and body mass to 
the nearest 0.1 kg (Seca876, Hamburg, Germany). Waist 
Table 1  Baseline participant 
characteristics according to 
asthma status and exercise 
group
Mean ± SD. ABP aortic blood pressure, AIx augmentation index, Aug augmentation, CHO cholesterol, DBP 
diastolic blood pressure, ESP end systolic pressure, HDL high density lipoprotein, HR heart rate, LDL low-
density lipoprotein, MAP mean arterial pressure, PWV pulse wave velocity, Q cardiac output, SBP systolic 
blood pressure, SEVR subendocardial viability ratio, SV stroke volume, ΤC Total Cholesterol, TG triglycer-
ides, TPR total peripheral resistance, WC waist circumference
Overall Asthma Healthy
Intervention Control Intervention Control
Sample size 65 16 17 16 16
Height (cm) 159.4 ± 9.3 161.4 ± 11.2 160.5 ± 9.4 157.5 ± 8.3 158.4 ± 8.4
Weight (kg) 54.1 ± 13.5 58.2 ± 15.0 57.1 ± 14.7 51.2 ± 13.4 50.1 ± 9.6
BMI (kg·m−2) 21.1 ± 3.3 22.1 ± 3.7 22.0 ± 4.2 20.3 ± 3.4 19.8 ± 2.8
WC (cm) 69.6 ± 10.0 70.9 ± 11.3 72.4 ± 12.0 68.1 ± 8.6 66.8 ± 7.1
SBP (mmHg) 123 ± 13 122 ± 12 126 ± 14 119 ± 12 126 ± 11
DBP (mmHg) 72 ± 10 72 ± 6 74 ± 12 70 ± 9 74 ± 11
ABP (mmHg) 111 ± 8 113 ± 6 111 ± 11 109 ± 7 110 ± 6
MAP (mmHg) 83 ± 6 84 ± 5 83 ± 6 83 ± 6 82 ± 6
SV (ml) 92.4 ± 16.2 93.3 ± 14.3 94.3 ± 22.9 88.3 ± 10.8 94.6 ± 16.0
HR (bpm) 72 ± 12 72.5 ± 10.0 72 ± 9 73 ± 16 68 ± 11
Q (l·min−1) 6.8 ± 1.6 7.0 ± 1.5 7.0 ± 1.9 6.6 ± 1.3 6.6 ± 1.6
TPR (PRU) 0.8 ± 0.2 0.8 ± 0.3 0.8 ± 0.3 0.8 ± 0.1 0.8 ± 0.2
ESP (mmHg) 96.0 ± 9.8 95.3 ± 11.1 96.8 ± 10.3 95.2 ± 8.7 96.9 ± 10.1
SEVR (%) 160.8 ± 60.1 156.5 ± 66.4 167.4 ± 69.6 148.3 ± 34.1 173.4 ± 69.4
PWV (m  s−1) 5.5 ± 0.6 5.6 ± 0.6 5.6 ± 0.5 5.7 ± 0.7 5.4 ± 0.5
Aug (mmHg) 4.8 ± 3.5 4.7 ± 3.4 4.5 ± 3.2 4.5 ± 3.3 5.5 ± 3.1
AIx (%) 9.2 ± 6.6 9.1 ± 6.4 8.6 ± 4.8 9.0 ± 5.8 10.2 ± 6.0
HDL (mmol·l−1) 1.5 ± 0.4 1.3 ± 0.4 1.5 ± 0.4 1.6 ± 0.2 1.5 ± 0.5
ΤC:HDL 2.6 ± 0.6 2.9 ± 0.6 2.7 ± 0.8 2.5 ± 0.4 2.4 ± 0.6
CHO (mmol·l−1) 3.6 ± 0.7 3.6 ± 0.7 3.7 ± 0.5 3.7 ± 0.4 3.3 ± 1.1
LDL (mmol·l−1) 1.6 ± 0.5 1.7 ± 0.5 1.6 ± 0.7 1.6 ± 0.5 1.6 ± 0.4
TG (mmol·l−1) 1.1 ± 0.6 1.1 ± 0.3 1.2 ± 1.1 1.2 ± 0.3 0.9 ± 0.3
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circumference was measured using a tape measure to the 
nearest 0.01 m (Seca 203, Hamburg, Germany) and taken at 
the waist, at the most indented point of the torso between the 
bottom of the rib cage and the iliac crest. Lower limb length 
was calculated as the difference between stature and sitting 
stature and subsequently used to estimate maturity offset 
using the equations of Mirwald et al. (2002).
Vascular assessment
Participants were supine with their torso at 35° and rested 
for five minutes prior to arterial stiffness assessment. The 
Vicorder (Skidmore Medical Limited, Bristol, UK) was 
used for pulse wave analysis (PWA) and the measurement 
of carotid-femoral PWV and hemodynamic variables (car-
diac output, stroke volume, total peripheral resistance, heart 
rate, end systolic pressure, subendocardial viability ratio). 
For PWA, a Hokanson SC10 cuff was positioned around the 
right arm. The cuff was inflated to measure blood pressure 
and then re-inflated to record the brachial artery pressure 
waveform. From this waveform, augmentation pressure, aug-
mentation index and central blood pressure (alongside other 
hemodynamic measures) were determined using a transfer 
function integral to the software. For PWV measurement, 
a sensor was positioned around the neck and a Hokanson 
SC10 cuff placed around the thigh. Path length was defined 
as the distance from the suprasternal notch to the middle of 
the thigh cuff. Three measures were taken for both PWA and 
PWV, of which the median values were used for analyses.
Cardiometabolic risk factors
Peripheral systolic and diastolic blood pressures were meas-
ured using the Omron MX3 Plus monitor (Model HEM-
742-E; Omron Healthcare UK, Milton Keynes, UK). Meas-
ures were taken from participants whilst seated, following at 
least 5 min rest. A minimum of two readings were obtained, 
with the mean used for subsequent analysis. Non-fasted 
blood lipid (total cholesterol (TC), HDL cholesterol and TG) 
and glucose profiles were determined from fingertip capil-
lary blood samples via the CardioCheck device (Polymer 
Technology Systems Inc., Indianapolis, USA), a reliable and 
valid alternative to gold standard methods for cardiovascular 
risk screening (Gao et al. 2016). In accord with previous 
research, non-fasted samples were used given that they do 
not differ to non-fasted samples in a clinically meaningful 
manner and may be more representative of normal meta-
bolic conditions (Langsted et al. 2008; Sidhu and Naugler 
2012). Consequently, low-density lipoprotein cholesterol 
(LDL) was not utilized in the analysis as the assumption of a 
constant triglyceride to cholesterol ratio in very low-density 
lipoprotein particles required for the Friedewald equation is 
likely to be violated in the non-fasting state (Krishnaveni 
and Gowda 2015).
Lung function
Lung function was measured using a portable dry spirometer 
(Alpha Spirometer, Vitalograph, Buckingham, UK). Each 
participant was asked to complete three maximal exhala-
tions according to the American Thoracic Society guidelines 
(1995); exhalations were defined as acceptable if they were 
all within 5%. Subsequently, the best exhalation was selected 
and the forced expiratory volume in one second  (FEV1) and 
forced vital capacity (FVC) were expressed as a percentage 
of age, sex and stature specific predicted values (Quanjer 
et al. 2012).
Fractional exhaled nitric oxide (FeNO) was measured in 
accordance with the American Thoracic Society guidelines 
(Dweik et al. 2011) using the NIOX MINO (Aerocrine AB, 
Solna, Sweden). Visual and audio cues were provided by 
the computer software throughout each effort, with the final 
three seconds of exhalation evaluated.
Statistical analysis
Statistical analysis was conducted in SPSS v 23 (IBM SPSS 
Statistics Inc., Chicago, IL, USA) and STATA v 15 (Stata-
Corp LP, Texas, USA). Chi-square analysis was used to 
determine differences in the proportion of participants who 
had asthma by sex, whilst a Mann–Whitney test was used 
to determine differences in age by asthma status. Principal 
component factor analysis (PCA) was conducted to model 
the interrelationships between variables by identifying the 
common variance among the variables. Specifically, PCA 
was used to identify clustered cardiometabolic risk factors 
from the anthropometric, arterial stiffness and cardiomet-
abolic variables at baseline, with final estimates of com-
munalities iterated from squared multiple item correlations 
to convergence. Kaiser’s criterion (Eigenvalues >  = 1.0), 
together with Cattell’s scree test, were used to determine 
the number of underlying factors. An orthogonal varimax 
rotation was performed on the principal components and 
an overall cardiometabolic score was calculated at each 
time-point by summing the factor scores identified from the 
baseline data.
Mixed linear regression models within STATA were used 
to determine the overall effects of time, the intervention and 
asthma status, and their interactions, on individual and clus-
tered cardiometabolic risk factors and on the overall cardio-
metabolic score. Given that the interactions of group and 
asthma status were not significant, these interactions were 
subsequently removed from all models. A random intercept 
was included in each model to account for the repeated 
measures nature of the data, with all models controlling for 
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age, sex and percentage adherence. Pearson’s Correlation 
Coefficients were used to assess the relationship between 
lung function and vascular function.
Results
At baseline, there were no significant differences accord-
ing to group (control or intervention) or asthma status in 
anthropometrics, blood lipids, vascular function or hemo-
dynamic parameters (Table 1). Furthermore, there was 
no significant difference in age (Z = − 0.440, p = 0.660) 
or sex (χ2 = 0.843, p = 0.359). Those with asthma in the 
intervention group were characterized as 87% with mild 
persistent and 13% with moderate/severe asthma; in the 
control group, those with asthma were categorized as 77 
and 23% mild and moderate/severe, respectively. All of 
those with asthma were taking took short-acting β2 ago-
nists, with 71% of these participants also taking inhaled 
corticosteroids. There were no differences in lung function 
between those with asthma in the intervention or control 
groups  (FEV1%predicted: 95 ± 21 vs. 96 ± 28%;  FVC%predicted: 
105 ± 13 vs 98 ± 14% predicted; P = 0.85 and P = 0.11, 
respectively). There were no adverse events reported dur-
ing the intervention in either group.
When the parameters of cardiometabolic risk were 
considered separately (Table 2), a significant intervention 
effect was evident, with a lower LDL (β = 0.4 (0.06–0.68) 
mmol·l−1; P = 0.019) in the intervention group at mid-
intervention. Furthermore, the intervention group had a 
lower diastolic blood pressure at mid-intervention (β = 4.3 
(0.4–8.1) mmHg; P = 0.029) and higher subendocardial via-
bility ratio post-intervention (β = − 68.7 (−117.6 to −19.8) 
%; P = 0.006) than the control group. Whilst there was a sig-
nificant effect of time on augmentation index (AIx), which 
was higher at follow-up (β = 3.27 (0.39–6.14) %; P = 0.026), 
there was no effect of the intervention or asthma. In con-
trast, there was a significant interaction between asthma and 
time on PWV, which was higher post-intervention in those 
with asthma (β = 0.44 (0.05–0.84) m·s−1; P = 0.028). There 
were no correlations between any lung and vascular function 
parameters at any time-point.
Table 2  Participant characteristics at each time-point according to exercise group
Mean ± SD. ABP aortic blood pressure, AIx, augmentation index, Aug augmentation, CHO cholesterol, DBP diastolic blood pressure, ESP end 
systolic pressure, HDL high density lipoprotein, HR heart rate, LDL low-density lipoprotein, MAP mean arterial pressure, PWV pulse wave 
velocity, Q cardiac output, SBP systolic blood pressure, SEVR subendocardial viability ratio, SV stroke volume, ΤC Total cholesterol, TG triglyc-
erides, TPR total peripheral resistance, WC waist circumference
*Significant difference between intervention and control within time-point, P < 0.05
Baseline Mid-intervention Post-intervention Follow-Up
Intervention Control Intervention Control Intervention Control Intervention Control
Height (cm) 159.4 ± 9.8 159.5 ± 8.8 161.3 ± 10.1 161.7 ± 9.0 163.2 ± 10.1 163.0 ± 8.9 165.0 ± 9.8 163.3 ± 9.2
Weight (kg) 54.5 ± 14.4 53.7 ± 12.8 55.3 ± 14.2 54.8 ± 14.9 57.4 ± 15.8 57.0 ± 14.9 59.5 ± 15.6 56.6 ± 15.0
WC (cm) 69.4 ± 9.9 69.7 ± 10.2 69.6 ± 8.8 69.0 ± 10.7 70.2 ± 9.4 69.9 ± 9.4 71.1 ± 9.9 68.7 ± 9.3
SBP (mmHg) 120 ± 8 126 ± 13 123 ± 10 126 ± 13 120 ± 10 121 ± 10 119 ± 10 120 ± 12
DBP (mmHg) 71 ± 5 74 ± 11 72 ± 12 74 ±  11* 70 ± 7 68 ± 10 69 ± 8.1 66 ± 8
ABP (mmHg) 111 ± 7 111 ± 8.5 112 ± 7 112 ± 7 110 ± 7 111 ± 9 111 ± 8 111 ± 10
MAP (mmHg) 84 ± 6 82 ± 6 85 ± 5 85 ± 5 82 ± 6 82 ± 6 83 ± 6 83 ± 8
SV (ml) 90.7 ± 12.6 94.4 ± 19.5 91.0 ± 17.3 92.3 ± 15.7 92.1 ± 18.6 95.8 ± 20.2 93.4 ± 16.7 95.2 ± 15.6
HR (bpm) 73 ± 13 70 ± 10 75 ± 15 74 ± 12 68 ± 12 68 ± 11 72 ± 12 69 ± 11
Q (l·min−1) 6.8 ± 1.4 6.8 ± 1.8 6.8 ± 2.0 6.8 ± 1.7 6.3 ± 1.7 6.9 ± 1.7 6.9 ± 1.6 6.8 ± 1.5
TPR (PRU) 0.8 ± 0.2 0.8 ± 0.3 0.8 ± 0.3 0.8 ± 0.3 0.8 ± 0.3 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2
ESP (mmHg) 95.3 ± 9.7 96.8 ± 10.0 97.7 ± 10.3 98.0 ± 10.5 96.9 ± 10.2 94.2 ± 11.5 93.3 ± 13.8 93.9 ± 11.2
SEVR (%) 152.2 ± 51.1 170.3 ± 68.3 168.3 ± 71.8 163.6 ± 58.8 188.5 ± 80.1 161.6 ± 65.9* 148.6 ± 65.8 152.9 ± 52.8
PWV (m  s−1) 5.6 ± 0.6 5.5 ± 0.5 5.7 ± 0.4 5.6 ± 0.3 5.6 ± 0.6 5.5 ± 0.5 5.7 ± 0.6 5.6 ± 0.6
Aug (mmHg) 5.3 ± 3.0 5.4 ± 3.6 4.4 ± 3.0 3.9 ± 3.0 4.3 ± 2.3 5.5 ± 3.5 6.5 ± 3.4 5.3 + 3.6
AIx (%) 9.3 ± 5.9 9.7 ± 7.2 8.6 ± 5.4 7.6 ± 5.6 7.9 ± 4.3 10.4 ± 6.2 12.4 ± 5.7 10.0 ± 6.3
HDL (mmol·l−1) 1.1 ± 0.3 1.5 ± 0.4 1.4 ± 0.3 1.5 ± 0.3 1.6 ± 0.4 1.4 ± 0.5 1.4 ± 0.3 1.3 ± 0.3
ΤC:HDL 2.7 ± 0.6 2.6 ± 0.7 2.5 ± 0.6 2.6 ± 0.6 2.4 ± 0.7 2.5 ± 0.6 2.7 ± 0.7 2.6 ± 0.8
CHO (mmol·l−1) 3.6 ± 0.6 3.5 ± 0.9 3.4 ± 0.5 3.7 ± 0.5 3.6 ± 0.6 3.6 ± 0.6 3.5 ± 0.5 3.5 ± 0.4
LDL (mmol·l−1) 1.7 ± 0.5 1.6 ± 0.5 1.5 ± 0.5 1.7 ± 0.4* 1.6 ± 0.5 1.6 ± 0.5 1.7 ± 0.4 1.5 ± 0.6
TG (mmol·l−1) 1.1 ± 0.3 1.1 ± 0.8 1.1 ± 0.6 1.1 ± 0.6 1.0 ± 0.5 1.1 ± 0.9 1.1 ± 0.5 1.1 ± 0.6
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The principal component analysis extracted seven factors 
from the baseline data, accounting for 88% of the common 
variance between parameters, with factor loadings ranging 
from 0.44 to 0.95 (Table 3). The seven factors were labeled: 
a blood pressure/stroke volume factor, an adiposity factor, 
a hemodynamic/perfusion factor, a hemodynamic/arterial 
stiffness factor, a cholesterol factor, a wave reflection factor 
and a TG factor. The summed risk scores for each factor 
are shown in Tables 4 and 5 according to asthma and inter-
vention group, respectively. After taking into account age 
and sex, the results indicate there were no statistically sig-
nificant differences between summed factor scores accord-
ing to time-point or asthma status for the blood pressure/
stroke volume, adiposity, hemodynamic/perfusion, wave 
reflection or TG factors (all P > 0.05). Participants with 
asthma had significantly lower hemodynamic/arterial stiff-
ness scores mid-intervention (β = − 8.87 (confidence inter-
vals: − 17.70–− 0.04); P = 0.049) and lower cholesterol 
scores at post-intervention (β = 0.60 (confidence intervals: 
0.07–1.13); P = 0.028), compared to healthy controls. There 
was no effect of the intervention, or interaction between 
asthma and the intervention, for any of the other factors at 
any time-point.
There was no association between markers of lung 
function and those of arterial stiffness at baseline or mid-
intervention but, at post-intervention, FeNO was inversely 
associated with augmentation (r = − 0.42, P = 0.029) and 
augmentation index (r = − 0.40, P = 0.039). There was no 
relationship between arterial stiffness markers and the indi-
vidual markers of cardiometabolic risk.
Table 3  Factor loadings of the principal component analysis
ABP aortic blood pressure, AIx augmentation index, Aug augmentation, CHO cholesterol, CV cumulative variance, DBP diastolic blood pres-
sure, ESP end systolic pressure, HDL high density lipoprotein, HR heart rate, LDL low-density lipoprotein, MAP mean arterial pressure, PWV 
pulse wave velocity, Q cardiac output, SBP systolic blood pressure, SEVR subendocardial viability ratio, SV stroke volume, ΤC Total cholesterol, 







Cholesterol Wave reflection Triglycerides
SBP 0.794 – – – – – –
Aortic PP 0.947 – – – – – –
Aortic BP 0.769 – – – – – –
PP 0.922 – – – – – –
SV 0.757 – – – – – –
Height – 0.730 – – – – –
Weight – 0.909 – – – – –
WC – 0.867 – – – – –
HDL – − 0.851 – – – – –
TC/HDL – 0.795 – – – – –
Q – – − 0.754 – – – –
TPR – – 0.894 – – – –
ESP – – 0.709 – – – –
SEVR – – 0.949 – – – –
MAP – – – 0.912 – – –
HR – – – 0.642 – – –
PWV – – – 0.442 – – –
DBP – – – 0.865 – – –
CHO – – – – 0.980 – –
LDL – – – – 0.977 – –
Aug – – – – – 0.783 –
Aix – – – – – 0.952 –
TG – – – – – – 0.879
Eigenvalue 5.6 3.8 3.2 2.4 2.3 1.7 1.1
% VE 24.3 16.7 14.1 10.4 10.0 7.2 4.9
% CV 24.3 41.0 55.1 65.5 75.5 82.8 87.6
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Discussion
The main findings of this study were that the cardio-
metabolic health of adolescents can be almost entirely 
explained (88%) by seven factors identified by principal 
component analysis and that the clustering of these risk 
factors is not dependent on asthma status. The seven fac-
tors identified were blood pressure/stroke volume, adi-
posity, hemodynamic/perfusion, hemodynamic/arterial 
stiffness, cholesterol, wave reflection and TGs. Further-
more, in the longest school-based HIIT intervention to 
date, we observed no changes in clustered cardiometa-
bolic risk throughout the intervention period, despite the 
intervention being associated with an improved blood 
lipid and blood pressure profile mid-intervention. Impor-
tantly, asthma status did not influence the cardiometabolic 
response to the HIIT intervention.
Asthma is characterized by fluctuating airway and sys-
temic inflammation (Expert Panel Report 3 2007), with 
chronic inflammation suggested to be associated with 
increased arterial stiffness and, subsequently, cardiovas-
cular morbidity (Tousoulis et al. 2011; Labat et al. 2013). 
Indeed, it has previously been reported that children with 
asthma may demonstrate a higher PWV than their healthy 
counterparts (Steinmann et al. 2015) and an increased 
carotid intima media thickness (Dratva et al. 2018). In 
contrast, the present findings demonstrate no influence 
of asthma on markers of arterial stiffness and, in agree-
ment with Augusto et al. (2017), neither FeNO nor lung 
function were associated with arterial stiffness, except at 
post-intervention. These discordant findings may reflect 
physiological and/or methodological factors. Specifically, 
inter-study differences in the severity or control of asthma 
within the participants could, at least in part, explain these 
findings, with the adolescents in the current study char-
acterized by relatively mild, well-controlled asthma who 
may be anticipated to have minimal derangements in vas-
cular function. Indeed, it is feasible that the influence of 
asthma on arterial stiffness in the present study may have 
been masked by a mis-diagnosis of asthma or by a self-
selection bias amongst the adolescents with asthma due 
to the exercise-based nature of this study. However, it is 
also pertinent to note the male bias within Steinmann et al. 
(2015) given that boys with asthma are suggested to be 
more at risk of early vascular changes. Further conclusions 
Table 4  Mean values for PCA-identified factors according to time and asthma status
PWV pulse wave velocity, SV stroke volume
Baseline Mid-intervention Post-intervention Follow-up
Healthy Asthma Healthy Asthma Healthy Asthma Healthy Asthma
Blood pressure/SV 426.4 440.6 430.6 434.0 431.2 438.4 432.6 432.5
Adiposity 279.7 294.0 272.6 295.7 286.3 300.9 287.8 304.1
Haemodynamic/Perfusion 263.0 265.8 275.8 262.9 281.7 271.1 234.1 257.7
Hemodynamic/Arterial Stiffness 218.3 222.1 225.4 217.1 215.1 210.0 217.5 214.8
Cholesterol 5.3 5.2 5.2 5.1 4.8 5.3 5.0 5.1
Wave reflection 14.2 13.4 12.7 10.9 14.0 12.8 17.5 16.4
Triglycerides 1.0 1.2 0.9 1.2 1.0 1.1 1.1 1.1
Total 1178.8 1211.2 1099.3 1127.1 1079.1 1128.8 1057.8 1107.8
Table 5  Mean values for PCA identified factors according to time and group
PWV pulse wave velocity, SV stroke volume
Baseline Mid-intervention Post-intervention Follow-up
Intervention Control Intervention Control Intervention Control Intervention Control
Blood pressure/SV 428.5 438.7 433.6 431.0 435.4 434.2 433.0 432.1
Adiposity 287.1 286.3 289.8 277.9 294.2 291.7 299.0 290.6
Haemodynamic/Perfusion 255.0 274.7 273.6 265.1 292.5 260.3 249.5 251.4
Hemodynamic/Arterial Stiffness 223.6 216.4 222.9 219.7 214.2 211.0 220.0 211.9
Cholesterol 5.3 5.1 4.9 5.3 5.1 5.1 5.0 5.0
Wave reflection 13.6 14.1 12.6 11.0 11.6 15.3 18.2 15.6
Triglycerides 1.1 1.1 1.1 1.1 1.0 1.1 1.1 1.1
Total 1213.8 1175.0 1131.1 1044.3 1105.8 1051.3 1081.3 1031.4
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regarding these discrepancies are limited by inter-study 
differences in the devices used to determine PWV and in 
the estimation of pulse wave travel distances (Weber et al. 
2009). Longitudinal studies that incorporate a range of dis-
ease severities and account for the concomitant influences 
of age, maturation, sex and fitness are needed to further 
elucidate the influence of asthma on the arterial stiffness, 
and thus cardiovascular morbidity risk, of adolescents.
It is suggested that cardiovascular and metabolic disease 
risk may be increased in those with asthma due to elevated 
systematic inflammatory mediators (Uzunlulu et al. 2011). 
However, few have investigated the influence of asthma on 
cardiometabolic health, with the majority of those that have 
concentrating on the concomitant and potentially synergistic 
effects of obesity and asthma (Forno et al. 2015). The cur-
rent findings regarding a similar clustering of cardiometa-
bolic risk factors irrespective of asthma status in normal 
weight youth are therefore of interest. Indeed, our findings 
are in accord with previous exploratory factor analysis stud-
ies in children that have consistently highlighted that a single 
factor cannot explain the cardiometabolic health of youth 
(Goodman et al. 2009; Stoner et al. 2017; Lambert et al. 
2004). However, in contrast to the two-four factors most 
commonly reported elsewhere (Goodman et al. 2009; Stoner 
et al. 2017; Lambert et al. 2004), we identified seven fac-
tors that explained 88% of the variation in cardiometabolic 
health in the current adolescents. Whilst this greater number 
of factors may simply be consequent to a larger range of 
factors and types of risks considered in the present study 
(Meigs 2000), the heterogeneity in the factors identified may 
be indicative of separate metabolic processes rather than 
a single, unifying pathogenic phenomenon (Hanson et al. 
2002; Lindblad et al. 2001). Indeed, it is interesting to note 
the loading of AIx and PWV onto separate factors in the 
present study, both of which were also independent of blood 
pressure. An increased arterial stiffness is associated with a 
greater PWV, resulting in the reflected wave arriving back at 
the ascending aorta during systole, augmenting aortic (cen-
tral) blood pressure. Despite the interdependence of this pro-
cess, the findings of this study support those of Stoner et al. 
(2017) that AIx and blood pressure represent different under-
lying physiological constructs, and extends this conclusion 
to PWV. The present findings therefore reinforce the notion 
that both AIx and PWV may be important cardiovascular 
measures in youth (Thurn et al. 2015).
It is increasingly recognized that the cardiometabolic 
benefits of MVPA are principally attributable to the vigor-
ous element of this metric, despite this typically accounting 
for only a small proportion of a youth’s total daily physical 
activity (~ 4 min; Carson et al. 2014). In combination with 
the commonly cited barrier that youth do not have enough 
time to engage in sufficient physical activity, this has led 
to a growing interest in the potential efficacy of HIIT at 
improving the cardiometabolic health of youth, with the 
general consensus of recent systematic reviews and meta-
analyses being that HIIT may be beneficial (Logan et al. 
2014; Costigan et al. 2015; Eddolls et al. 2017). However, 
the majority of the studies underpinning these reviews have 
involved traditional exercise modalities, such as sprinting 
(running or cycling), the long-term sustainability of which is 
questionable (Weston et al. 2016). Furthermore, the majority 
have considered the influence of HIIT on individual mark-
ers of cardiometabolic risk despite the clustering of factors 
having been acknowledged for many years (Reaven 1988). 
A single factor is unlikely to define cardiometabolic health 
in youth (Stoner et al. 2017) and thus influencing individual 
factors does not necessarily translate to beneficial changes in 
the overall risk score. Indeed, in the current study, HIIT did 
not influence clustered cardiometabolic risk, irrespective of 
asthma status, despite being associated with improved blood 
pressure and lipids at mid-intervention. This lack of transla-
tion to global cardiometabolic benefit may be indicative that 
the changes were not sustained for a sufficient period, pos-
sibly due to insufficient progression within the HIIT protocol 
throughout the 6-month period, or that these factors are not 
the most influential in determining overall cardiometabolic 
health. With regards to those with asthma, it is possible that 
the parameters of cardiometabolic risk considered in this 
study are not those primarily effected by/involved in this 
condition; the key parameters largely remain to be elucidated 
and are likely dependent on numerous factors such as weight 
status, age, sex, and the specific asthma phenotype. Further-
more, future research should consider including a confir-
mation of asthma diagnosis to avoid potential confounding 
effects associated with the mis-diagnosis of asthma.
There is little consensus regarding the influence of exer-
cise on arterial stiffness in youth. Ratgeber et al. (2015) 
similarly found no influence in a cross-sectional compari-
son of trained and untrained children, others have reported 
significantly lower arterial stiffness following HIIT (Chuen-
siri et al. 2018), circuit training (Watts et al. 2004), aero-
bic training (Meyer et al. 2006) or a combined aerobic and 
resistance training protocol (Farpour-Lambert et al. 2009). 
The variation in the training protocols and the use of flow-
mediated dilation or PWV to assess arterial stiffness limit 
conclusions regarding the basis for these equivocal findings. 
Indeed, whilst both flow-mediated dilation and PWV provide 
insights to vascular function, it is important to note their 
different vascular physiological implications, with FMD 
reflecting nitric oxide bioavailability as a marker of endothe-
lial health and increasing PWV reflecting adverse structural 
changes in the arterial wall. However, it is worthy of note 
that advantageous influences of exercise on arterial stiffness 
have only been reported in obese children (Chuensiri et al. 
2018; Watts et al. 2004; Farpour-Lambert et al. 2009; Meyer 
et al. 2006). This may reflect the absence of derangements 
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in vascular function in normal weight children, limiting the 
potential benefits that can be elicited through HIIT. Further 
research is nonetheless required to elucidate the potential 
efficacy of HIIT in overweight and obese youth with asthma, 
an increasingly common phenotype (Di Genova et al. 2018). 
Alternatively, the lack of beneficial effect in the present 
study may reflect an insufficient exercise intensity; whist 
the minimum exercise intensity required to elicit improve-
ments remains to be elucidated, low-to-moderate intensity 
exercise has previously been reported to be ineffective at 
improving vascular function (Farpour-Lambert et al. 2009; 
Ashor et al. 2015).
As the longest HIIT intervention in children to date, and 
first to consider PWV and AIx, the present study extends our 
understanding of potential strategies to mitigate an increased 
cardiometabolic risk in youth, highlighting that those with 
mild-to-moderate asthma should be considered similarly to 
their non-asthma peers. Nonetheless, several potential limi-
tations should be considered. First, the majority of the par-
ticipants were Caucasian adolescents recruited from a pre-
dominately urban area; combined with the sample size these 
considerations may limit the generalizability of the findings. 
Furthermore, adiposity was estimated indirectly using com-
mon epidemiological measures, which could not distinguish 
the independent role of fat and fat-free mass in determining 
cardiometabolic risk and its response to HIIT. An impor-
tant limitation of the current study was that the majority 
of those with asthma were characterized as mild and well 
controlled, potentially due to a self-selection bias; it is pos-
sible that cardiometabolic abnormalities would have been 
more apparent in those with more severe asthma. It is also 
important to highlight that self-reported GP diagnosis was 
used. However, the current range of disease severities is pro-
portionally representative of the general asthma population. 
It is also pertinent to note, however, that asthma diagnoses 
in the current study were not verified using reversibility or 
other challenge tests which may result in the overdiagnosis 
of asthma. As with any long-term intervention study, poor 
adherence of some participants may have limited the overall 
influence of the intervention, but the current school-based 
delivery method increases the ecological validity of the find-
ings rather than a contrived laboratory-based intervention.
Conclusion
In conclusion, adolescents with controlled, mild asthma do 
not demonstrate any discernible differences in arterial stiff-
ness compared to their healthy peers. Furthermore, neither 
arterial stiffness nor clustered cardiometabolic risk are influ-
enced by a 6-month school-based HIIT intervention in ado-
lescents. The present findings highlight that blood pressure, 
AIx and PWV should be considered physiologically distinct 
constructs that warrant further investigation as potential 
markers of cardiovascular health in children.
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